New registry to track Heat-Based tumor ablation for pancreatic lesions
NCT ID NCT07625189
First seen Jun 09, 2026 · Last updated Jun 23, 2026 · Updated 3 times
Summary
This registry will follow 50 adults undergoing endoscopic ultrasound (EUS)-guided radiofrequency or microwave ablation for pancreatic or other gastrointestinal lesions as part of their routine care. Researchers will track changes in tumor size, survival, tumor markers, and side effects over 12 months. The goal is to gather real-world data on how well these ablation techniques work.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABLATION TECHNIQUES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West Virginia University
RECRUITINGMorgantown, West Virginia, 26505, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiofrequency ablation (RFA) or microwave ablation (MWA)
What this could lead to
If successful, this registry could provide real-world evidence on how well these ablation techniques work for pancreatic and GI lesions, potentially guiding future treatment decisions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be limited by small size (50 participants) and lack of a comparison group.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.